Search

everythinglearnresearchcommunity

for

Search:↓

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

The development of breeding tubercles in male zebrafish relies on a specific enzyme that processes hormones.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Compound 4 is a promising treatment for hair loss with low toxicity.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.